7 unchanged sentences
Trerotola 57 Chief Executive Officer and Chair of the Board of Directors
−Removed: Shirley 58 President, Chief Operating Officer and Director
Berry 46 Senior Vice President and Chief Financial Officer
Pryor 56 Executive Vice President, Strategy and Business Development
−Removed: Tandy 65 Senior Vice President and General Counsel
+Added: Tandy 66 Senior Vice President and Chief Legal Officer
Patricia Lang 61 Senior Vice President and Chief Human Resources Officer
14 unchanged sentences
Trerotola is a director of AptarGroup, Inc.
−Removed: Shirley has been President and Chief Operating Officer, and has served as a director of the Company, since April 2022.
−Removed: Prior to this, Mr.
−Removed: Shirley was DJO Chief Executive Officer from 2016 to 2022 and served as the President of the DJO Surgical business, a position he was appointed to in March of 2014.
−Removed: From 2009 to 2013, Mr.
−Removed: Shirley was the CEO and Director of Innovative Medical Device Solutions (“IMDS”), a company that provides comprehensive product development, manufacturing and supply chain management solutions for medical device companies within the orthopedic medical device industry.
−Removed: Shirley managed the integration of four companies, consolidated the capital structure and led a successful sale of the business in 2013.
−Removed: From December 1992 to August 2009, Mr.
−Removed: Shirley had several key leadership positions with Stryker Corporation, including President of Stryker Communications and Senior Vice President of Stryker Endoscopy.
−Removed: Shirley received a Bachelor of Business Administration in Finance from the University of Texas, Austin.
Berry has been Chief Financial Officer since January 1, 2023.
−Removed: He joined the Company in 2020, initially serving as chief financial officer of the Company’s medical technology segment, and serving as chief financial officer of those business units following the Separation.
+Added: He joined the Company (then known as Colfax) in 2020, initially serving as chief financial officer of the medical technology segment, and serving as chief financial officer of the Recon and P&R segments following the Separation.
Previously, he spent 18 years in the medical technologies sector with Novartis/Alcon, which included its launch of Alcon as an independent public company in 2019.
12 unchanged sentences
From February 2020 to April 2022, he served as our Corporate Secretary.
−Removed: Tandy also served in
−Removed: his capacity as Executive Vice President, General Counsel and Secretary of DJO.
+Added: Tandy also served in his capacity as Executive Vice President, General Counsel and Secretary of DJO.
Prior to joining DJO, Mr.
11 unchanged sentences
Lang was the Chief People Officer for Diebold Nixdorf and was responsible for managing employee-focused initiatives across the organization.
−Removed: Prior to joining Diebold Nixdorf, Ms.
+Added: Prior to joining Diebold
Lang held a number of human resource and operations leadership positions at companies such as Mylan Pharmaceuticals, Consol Energy, Mercer Consulting and Cigna.
13 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.